Dr. David Atteberry Nethery, MD

Dr. Nethery practices at Baylor Scott & White Surgicare - Cityview in Fort Worth, Texas.

Dr. Nethery's NPI, 1548264443, was assigned on June 8, 2005. Dr. Nethery graduated from Texas Tech University Health Sciences Center School of Medicine in 1996. Dr. Nethery's Texas license number on file is K8377.

Dr. Nethery's primary practice is Baylor Scott & White Surgicare - Cityview, at 6551 Harris Parkway, Fort Worth, TX 76132. The practice phone is (817) 423-1800.

Dr. Nethery's primary practice is Baylor Scott & White Surgicare - Cityview in Fort Worth, Texas. Dmand AI also links Dr. Nethery to 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Nethery practices, 2 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Nethery's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Nethery is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Nethery's licenses on file in 2 states: Texas and Louisiana.

Dmand AI lists age-related macular degeneration, cataract, cataract surgery with lens implant, conjunctivitis, dry eye, eye infection or inflammation, eyelid inflammation and glaucoma among the conditions Dr. Nethery treats.

CMS data shows 3,733 Medicare services from Dr. Nethery across 10 procedure codes in 2024, for 1,363 Medicare patients. Medicare paid $383,586 for them.

CMS counts 1,363 Medicare patients who saw Dr. Nethery in 2024. The largest group is 65 to 74, with 670 patients. 75% of them have high cholesterol, and 72% have high blood pressure. Their average risk score is 1.00, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Nethery's median patient age at 74, with 57% women.

In 2024, Dr. Nethery wrote 1,192 Medicare Part D claims for 402 patients. 61% of them were for generic drugs. CMS names the drug for 1,064 of them, across 17 drugs with 11 or more claims each, at $82,188 in total drug cost. In 2023, CMS named 1,201 claims across 19 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Nethery for performance year 2024, reported individually. Dr. Nethery accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 707 procedures of cataract surgery by Dr. Nethery, more than 98% of the clinicians it reports for that procedure.

Dmand AI links 2 papers to Dr. Nethery in 2013. The most frequent topics are Lens Implantation, Intraocular and Phacoemulsification. Dr. Nethery has published most often in J Cataract Refract Surg. Dr. Nethery's most frequent co-authors are Robert Paul Lehmann, MD and Thomas Richard Walters, MD.

CMS Open Payments shows 254 general payments to Dr. Nethery from 28 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 71% of the total. Alcon Research Ltd paid the most, $1,880.

Dmand AI lists 2 awards for Dr. Nethery, most recently AAO Fellow in 2013.

Dr. Nethery graduated from Texas Tech University Health Sciences Center School of Medicine in 1996. Dr. Nethery is a member of AAO.

Dr. Nethery is in network with 17 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.